Cubist Systematic Strategies’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$712K Buy
2023
Q2
Sell
2023
Q1
$60.3K Buy
2022
Q4
$5.48K Sell
2022
Q3
$16K Sell
2022
Q2
$23K Buy
2022
Q1
Sell
2021
Q4
$190K Buy